Sponsored Content: Press releases may be published as paid or sponsored content. The issuers of these press releases are solely responsible for their content. BioInformant is not responsible for the accuracy or claims made in these announcements and does not endorse the views expressed by their issuers.
Therapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing COPD
Phase III Clinical Trial Stem Cell Company Aims to Fast Forward Regenerative Solutions to Dreaded Lung Disease
November 9, 2022, ELK CITY, Idaho — Therapeutic Solutions International (TSOI) announced the launching of a spin-off company, Breathe Biologics, Inc., to commercialize technologies in the area of COPD. [Read more…]
Pan Cancer T and NecstGen Collaborate to Accelerate Novel TCR-T Therapies into Clinical Development
Rotterdam and Leiden, the Netherlands, November 23, 2022 – Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery and development of novel second generation TCR-T therapies against solid tumors, and NecstGen B.V., The Netherlands Center for the Clinical Advancement of Stem Cells and Gene Therapy, today announced a partnership to advance Pan Cancer T’s innovative therapies into the clinic. Under the agreement, NecstGen will provide process and analytical development capabilities. [Read more…]
Steakholder Foods® Successfully Produced Porcine Fat Cells Differentiated from iPSC for Cultivated Pork Products
This will enhance the company’s ability to produce high-quality structured pork products at scale.
REHOVOT, Israel, Nov. 10, 2022 — Steakholder Foods Ltd. (NASDAQ: STKH), (formerly MeaTech 3D: MITC), an international deep-tech food company at the forefront of the cultured meat industry, today announced that it has successfully differentiated porcine fat cells from its induced pluripotent stem cell line. [Read more…]
Novel Hydrogel System Eliminates Need For Subculture In Cell Culture Process While Retaining Key Cell Features, Reducing Number of Cells In Senescence, and Increasing Production of Therapeutic By-Products
November 16, 2022, Olathe, KS – Ronawk, the new biotech and biofabrication company powered by the Bio-Block™ platform, today shared highlights of new data published in the October issue of Regenerative Medicine. The article entitled “Novel Hydrogel System Eliminates and Improves Retainment of Non-Senescent Mesenchymal Stem Cell Populations” demonstrates the significant impact of Ronawk’s hydrogel Bio-Block™ system on the cell culture process and the ability to remove the need for subculture from the process. [Read more…]
- « Previous Page
- 1
- …
- 54
- 55
- 56
- 57
- 58
- …
- 118
- Next Page »